Immunogenicity and protective efficacy of yeast extracts containing rotavirus-like particles: A potential veterinary vaccine

Vaccine

Volumn 32, Issue 24, 2014, Pages 2794-2798

  Rodríguez Limas, William A ^a   Pastor, Ana Ruth ^a   Esquivel Soto, Ernesto ^b   Esquivel Guadarrama, Fernando ^b   Ramírez, Octavio T ^a   Palomares, Laura A ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Rotavirus; Vaccines for bovines, Virus like particles, Saccharomyces cerevisiae; Yeast

Indexed keywords

ROTAVIRUS PROTEIN; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG EFFICACY; FUNGAL STRAIN; IMMUNOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SACCHAROMYCES CEREVISIAE; VIRUS REPLICATION; VIRUS SHEDDING; YEAST;

ROTAVIRUS; VACCINES FOR BOVINES, VIRUS-LIKE PARTICLES, SACCHAROMYCES CEREVISIAE; YEAST;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; BATCH CELL CULTURE TECHNIQUES; CAPSID PROTEINS; FEMALE; MICE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SACCHAROMYCES CEREVISIAE; VACCINES, VIRUS-LIKE PARTICLE; VIRUS CULTIVATION; VIRUS SHEDDING;

EID: 84899967218     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.037     Document Type: Article

References (38)

1. Martella V., Banyai K., Matthijnssens J., Buonavoglia C., Ciarlet M. Zoonotic aspects of rotaviruses. Vet Microbiol 2010, 140(3-4):246-255.
2. Clark K.J., Tamborello T.J., Xu Z., Mann F.E., Bonnot C.E., Woode G.N. An unusual group-A rotavirus associated with an epidemic of diarrhea among three-month-old calves. J Am Vet Med Assoc 1996, 208(4):552-554.
3. Kim Y., Nielsen P.R., Hodgins D., Chang K.O., Saif L.J. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 2002, 20(7-8):1248-1258.
4. Rodriguez-Limas W.A., Flores-Samaniego B., de la Mora G., Ramirez O.T., Palomares L.A. Genotypification of bovine group A rotavirus in Mexico. Vaccine 2009, 27(46):6411-6414.
5. Gilliland S.M., Forrest L., Carre H., Jenkins A., Berry N., Martin J., et al. Investigation of porcine circovirus contamination in human vaccines. Biologicals 2012, 40(4):270-277.
6. Estes M.K., Kapikian A.Z. Rotaviruses and their replication. Fields virology 2007, 1919-1950. Lippincott Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman (Eds.).
7. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 2011, 156(8):1397-1413.
8. Santos N., Lima R.C., Pereira C.F., Gouvea V. Detection of rotavirus types G8 and G10 among Brazilian children with diarrhea. J Clin Microbiol 1998, 36(9):2727-2729.
9. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., et al. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 2008, 82(7):3204-3219.
10. Dunn S.J., Greenberg H.B., Ward R.L., Nakagomi O., Burns J.W., Vo P.T., et al. Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol 1993, 31(1):165-169.
11. Griffin D.D., Nakagomi T., Hoshino Y., Nakagomi O., Kirkwood C.D., Parashar U.D., et al. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology 2002, 294(2):256-269.
12. Ramani S., Kang G. Burden of disease & molecular epidemiology of group A rotavirus infections in India. Indian J Med Res 2007, 125(5):619-632.
13. Palomares L.A., Mena J.A., Ramirez O.T. Simultaneous expression of recombinant proteins in the insect cell-baculovirus system: production of virus-like particles. Methods 2012, 56(3):389-395.
14. Molinari P., Peralta A., Taboga O. Production of rotavirus-like particles in Spodoptera frugiperda larvae. J Virol Methods 2008, 147(2):364-367.
15. Motohashi T., Shimojima T., Fukagawa T., Maenaka K., Park E.Y. Efficient large-scale protein production of larvae and pupae of silkworm by Bombyx mori nuclear polyhedrosis virus bacmid system. Biochem Biophys Res Commun 2005, 326(3):564-569.
16. Laimbacher A.S., Esteban L.E., Castello A.A., Abdusetir Cerfoglio J.C., Arguelles M.H., Glikmann G., et al. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther 2012, 20(9):1810-1820.
17. Gonzalez S.A., Affranchino J.L. Assembly of double-layered virus-like particles in mammalian cells by coexpression of human rotavirus VP2 and VP6. J Gen Virol 1995, 76(Pt 9):2357-2360.
18. Fernandez F.M., Conner M.E., Hodgins D.C., Parwani A.V., Nielsen P.R., Crawford S.E., et al. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine 1998, 16(5):507-516.
19. Rodriguez-Limas W.A., Tyo K.E., Nielsen J., Ramirez O.T., Palomares L.A. Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae. Microb Cell Fact 2011, 10(1):33.
20. Xia M., Farkas T., Jiang X. Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts. J Med Virol 2007, 79(1):74-83.
21. Atkin A.L. Preparation of yeast cells for confocal microscopy. Confocal microscopy methods and protocols 1998, 131-139. Humana Press Inc., Totowa, NJ. S.W. Paddock (Ed.).
22. Plascencia-Villa G., Mena J.A., Castro-Acosta R.M., Fabian J.C., Ramirez O.T., Palomares L.A. Strategies for the purification and characterization of protein scaffolds for the production of hybrid nanobiomaterials. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879(15-16):1105-1111.
23. Lopez-Guerrero D.V., Meza-Perez S., Ramirez-Pliego O., Santana-Calderon M.A., Espino-Solis P., Gutierrez-Xicotencatl L., et al. Rotavirus infection activates dendritic cells from Peyer's patches in adult mice. J Virol 2010, 84(4):1856-1866.
24. Cassone A., Marconi P., Bistoni F., Mattia E., Sbaraglia G., Garaci E., et al. Immunoadjuvant effects of candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother 1981, 10(4):181-190.
25. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 2001, 7(5):625-629.
26. Bertolotti-Ciarlet A., Ciarlet M., Crawford S.E., Conner M.E., Estes M.K. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 2003, 21(25):3885-3900.
27. Choi A.H.C., Basu M., McNeal M.M., Clements J.D., Ward R.L. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol 1999, 73(9):7574-7581.
28. Ciarlet M., Crawford S.E., Barone C., Bertolotti-Ciarlet A., Ramig R.F., Estes M.K., et al. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol 1998, 72(11):9233-9246.
29. Jiang B., Estes M.K., Barone C., Barniak V., O'Neal C.M., Ottaiano A., et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 1999, 17(7):1005-1013.
30. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. J Virol 2001, 75(22):11010-11016.
31. Siadat-Pajouh M., Cai L. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Viral Immunol 2001, 14(1):31-47.
32. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 1997, 71(11):8707-8717.
33. Parez N., Fourgeux C., Mohamed A., Dubuquoy C., Pillot M., Dehee A., et al. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol 2006, 80(4):1752-1761.
34. Agnello D., Herve C.A., Lavaux A., Darniot M., Guillon P., Charpilienne A., et al. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice. J Virol 2006, 80(8):3823-3832.
35. Dharakul T., Labbe M., Cohen J., Bellamy A.R., Street J.E., Mackow E.R., et al. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J Virol 1991, 65(11):5928-5932.
36. Ward R.L., McNeal M.M. VP6: a candidate rotavirus vaccine. J Infect Dis 2010, 202(Suppl.):S101-S107.
37. Dennehy M., Bourn W., Steele D., Williamson A.L. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Vaccine 2007, 25(18):3646-3657.
38. McNeal M.M., Rae M.N., Bean J.A., Ward R.L. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol 1999, 73(9):7565-7573.